Jae Yeon Lee

Glomerulosclerosis in 2026: From Pathophysiological Mechanisms to Precision Therapeutics

Glomerulosclerosis is not an independent disease entity but rather a common histopathological endpoint shared by diverse glomerular diseases and chronic kidney disorders. It represents the final common pathway of progressive glomerular injury and is a major determinant of chronic...